Product Code: ETC200121 | Publication Date: May 2022 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Nuclear Medicine Radioisotopes Market - Industry Life Cycle |
3.4 United Kingdom (UK) Nuclear Medicine Radioisotopes Market - Porter's Five Forces |
3.5 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Types, 2021 & 2031F |
3.6 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume Share, By By Application, 2021 & 2031F |
4 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Trends |
6 United Kingdom (UK) Nuclear Medicine Radioisotopes Market, By Types |
6.1 United Kingdom (UK) Nuclear Medicine Radioisotopes Market, By By Types |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By By Types, 2021 - 2031F |
6.1.3 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Technetium-99m (Tc-99m), 2021 - 2031F |
6.1.4 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thallium-201 (Tl-201), 2021 - 2031F |
6.1.5 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine (I-123), 2021 - 2031F |
6.1.6 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Fluorine-18, 2021 - 2031F |
6.1.7 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Rubidium-82 (Rb-82), 2021 - 2031F |
6.1.8 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Iodine-131 (I-131), 2021 - 2031F |
6.1.9 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021 - 2031F |
6.1.10 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 United Kingdom (UK) Nuclear Medicine Radioisotopes Market, By By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.2.4 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Thyroid, 2021 - 2031F |
6.2.5 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.2.6 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenues & Volume, By Others, 2021 - 2031F |
7 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Export to Major Countries |
7.2 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Imports from Major Countries |
8 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Key Performance Indicators |
9 United Kingdom (UK) Nuclear Medicine Radioisotopes Market - Opportunity Assessment |
9.1 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Types, 2021 & 2031F |
9.2 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Opportunity Assessment, By By Application, 2021 & 2031F |
10 United Kingdom (UK) Nuclear Medicine Radioisotopes Market - Competitive Landscape |
10.1 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Nuclear Medicine Radioisotopes Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |